Evidence mapPaperPMID 20042772Full record

GuidelineDiabetes care2010

Standards of medical care in diabetes--2010.

American Diabetes Association

Erratum issued 4 registry-linked trialsAbstract readPractice Guideline
In one paragraph

Guideline in Diabetes care, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 4 registered trials, which are not on this map. Cited by 1,337 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,337citing papers in PubMed, 11 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02113332 phase2completedstarted 2013, after this paper: background citation

Addition of Liraglutide to Overweight Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections (MDI) With Inadequate Glycaemic Control

Ran2013Enrolled124Registered outcomes19Posted comparisons0ConditionsType 2 Diabetes MellitusArmsliraglutide, Placebo
Open the trial in the graph
NCT01136746 phase3terminatednot on this mapstarted 2011, after this paper: background citation

Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial

TypeinterventionalSponsorEli Lilly and CompanyRan2011 to 2011Enrolled16ConditionsHyperglycemiaArmsHuman regular insulin, Insulin lispro, Insulin glargine
NCT01955031 nacompletednot on this mapstarted 2013, after this paper: background citation

Effectiveness and Cost-effectiveness Analysis of a Telemonitoring Program on Lifestyle for People With Type 2 Diabetes at Home. Study Based on a Health Network in Diabetology.

TypeinterventionalSponsorUniversity Hospital, ToulouseRan2013 to 2019Enrolled282ConditionsType 2 DiabetesArmstelemonitoring, Usual care
NCT05378282 completednot on this mapstarted 2021, after this paper: background citation

Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics

TypeobservationalSponsorHospital Juarez de MexicoRan2021 to 2023Enrolled40ConditionsType 2 Diabetes, Type 2 Diabetes With Renal Manifestations
3 · Its place in the literature

Who cites it

1,337 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Guideline
  8. Pooled it
  9. Pooled it
  10. Protein restriction for diabetic kidney disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

1,277 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

1 author.

American Diabetes Association

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes MellitusHumansPhysiciansRisk FactorsUnited States

Identifiers

PMID20042772
PMCPMC2797382

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.